Key points on the revision of the Declaration of Helsinki, and introducing the Declaration of Taipei

 A recording of the webinar held on Thursday 7 March 2024

• This webinar looked at the changes proposed to the Declaration of Helsinki, due to be published in 2024.
• In particular, changes in consent requirements, the use of placebo in trials and significant terminology changes will be considered.
• The webinar will also outline the identifiable data storage requirements of the Declaration of Taipei, and the changes in the new Helsinki.
• The Declaration of Taipei covers the collection, storage and use of identifiable data and biological material beyond the individual care of patients.
• Impact on E8(R1) and E6(R3).